| Brooke Buum, FNP | |
|
101 Tower Rd Ste 120, Dakota Dunes, SD 57049-5011 | |
| (605) 217-4320 | |
| (605) 217-2948 |
| Full Name | Brooke Buum |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 2 Years |
| Location | 101 Tower Rd Ste 120, Dakota Dunes, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184350076 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A170111 (Iowa) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Nose And Throat Consultants And Hearing Services Plc | 9335249457 | 15 |
| Ear Nose And Throat Consultants And Hearing Services Plc | 9335249457 | 15 |
| Ear Nose And Throat Consultants And Hearing Services Plc | 9335249457 | 15 |
News Archive
Menopause symptoms are not just for midlife anymore, according to a new Mayo Clinic study published this month in the Journal of the North American Menopause Society.
Efforts to address HIV/AIDS in Rwanda have not included blind people, Jacques Sindayigaya, Handicap International's coordinator of a new program to address the virus in the population, said Monday during a workshop in Rwanda's capital of Kigali, the New Times/AllAfrica.com reports.
Ginger.io, the behavioral health analytics startup, today announced a $6.5 million Series A funding round led by Khosla Ventures.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings will be presented at the annual meeting of the American Society of Clinical Oncology, to be held June 4-8 in Chicago.
› Verified 4 days ago
| Entity Name | Ear Nose And Throat Consultants And Hearing Services Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114141546 PECOS PAC ID: 9335249457 Enrollment ID: O20070703000011 |
News Archive
Menopause symptoms are not just for midlife anymore, according to a new Mayo Clinic study published this month in the Journal of the North American Menopause Society.
Efforts to address HIV/AIDS in Rwanda have not included blind people, Jacques Sindayigaya, Handicap International's coordinator of a new program to address the virus in the population, said Monday during a workshop in Rwanda's capital of Kigali, the New Times/AllAfrica.com reports.
Ginger.io, the behavioral health analytics startup, today announced a $6.5 million Series A funding round led by Khosla Ventures.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings will be presented at the annual meeting of the American Society of Clinical Oncology, to be held June 4-8 in Chicago.
› Verified 4 days ago
| Entity Name | Hawarden Regional Healthcare |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1841261104 PECOS PAC ID: 0547257990 Enrollment ID: O20081002000123 |
News Archive
Menopause symptoms are not just for midlife anymore, according to a new Mayo Clinic study published this month in the Journal of the North American Menopause Society.
Efforts to address HIV/AIDS in Rwanda have not included blind people, Jacques Sindayigaya, Handicap International's coordinator of a new program to address the virus in the population, said Monday during a workshop in Rwanda's capital of Kigali, the New Times/AllAfrica.com reports.
Ginger.io, the behavioral health analytics startup, today announced a $6.5 million Series A funding round led by Khosla Ventures.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings will be presented at the annual meeting of the American Society of Clinical Oncology, to be held June 4-8 in Chicago.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Buum, FNP 101 Tower Rd Ste 120, Dakota Dunes, SD 57049-5011 Ph: (605) 217-4320 | Brooke Buum, FNP 101 Tower Rd Ste 120, Dakota Dunes, SD 57049-5011 Ph: (605) 217-4320 |
News Archive
Menopause symptoms are not just for midlife anymore, according to a new Mayo Clinic study published this month in the Journal of the North American Menopause Society.
Efforts to address HIV/AIDS in Rwanda have not included blind people, Jacques Sindayigaya, Handicap International's coordinator of a new program to address the virus in the population, said Monday during a workshop in Rwanda's capital of Kigali, the New Times/AllAfrica.com reports.
Ginger.io, the behavioral health analytics startup, today announced a $6.5 million Series A funding round led by Khosla Ventures.
Biogen Idec today announced enrollment of the first patient in a multicenter Phase II clinical trial designed to evaluate its investigational oral therapy BG-12 (dimethyl fumarate) in combination with commonly used first-line treatments in patients with relapsing-remitting multiple sclerosis (RRMS).
Aggressive treatment of anaplastic thyroid carcinoma has dramatically increased survival in the small group of patients who chose to undergo it, say physicians at Mayo Clinic. Their findings will be presented at the annual meeting of the American Society of Clinical Oncology, to be held June 4-8 in Chicago.
› Verified 4 days ago
Alexandria Lynn Kohn, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 711 N Sioux Point Rd, Suite 100, Dakota Dunes, SD 57049 Phone: 712-222-7960 Fax: 472-222-7961 | |
Ellen T Wengert, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 705 N Sioux Point Rd, Suite 100, Dakota Dunes, SD 57049 Phone: 605-217-5500 Fax: 605-217-5515 | |
Nicolle Marie Weaver, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Mrs. Rayna Lea Bernadine Mccormick, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 | |
Sandra Louise Shumaker, ACNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 921 Spyglass Cir, Cnos, Pc, Dakota Dunes, SD 57049 Phone: 712-490-8422 | |
Allison Faye Pedersen, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 575 N Sioux Point Rd, Dakota Dunes, SD 57049 Phone: 605-217-2667 Fax: 605-217-2900 |